Clinical Trials Directory

Trials / Completed

CompletedNCT01444976

The Effect of Sedation During Transesophageal Echocardiography on Heart Rate Variability

The Effect of Sedation During Transesophageal Echocardiography on Heart Rate Variability:A Comparison of Hypnotic Sedation With Medical Sedation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
76 (actual)
Sponsor
Bakirkoy Dr. Sadi Konuk Research and Training Hospital · Other Government
Sex
All
Age
18 Years – 83 Years
Healthy volunteers
Not accepted

Summary

There is no ideal sedation technique that can be used during Transesophageal Echocardiography (TEE), and the data concerning the effects of available sedation techniques on Heart Rate Variability (HRV) are limited. In this study the investigators aimed at comparing the effects of sedation through hypnotherapy with medical sedation achieved by midazolam on HRV.

Detailed description

Seventy-six patients with an indication of TEE will be recruited, the age range will be 18-83 years. In Group Topical (T) there are 26 patients who had the procedure under topical pharyngeal anesthesia, in Group Midazolam (D) there are 25 patients who will receive midazolam and in Group H there are 27 patients receiving hypnosis. All patients will have an IV access; throughout the procedure heart rate, rhythm ECG, peripheric O2 saturation will be monitored with a non-invasive monitor, blood pressure measurements were taken every 3 minutes. Rhythm Holter recordings will be obtained from all patients and TEE will be performed.

Conditions

Interventions

TypeNameDescription
DRUGlocal anesthesiapatients will receive only topical anesthesia with 1% lidocaine
BEHAVIORALhypnosisHypnosis will be performed by the same anesthesiologist according to indirect Erickson's method
DRUGMidazolamBefore insertion of the probe, the patients will be sedated with midazolam at a dose of 0,.05 mg/kg iv (to achieve a Ramsay Sedation Score of 2-3). If needed, additional iv doses (0.005 mg/kg) were given during the procedure.

Timeline

Start date
2010-12-01
Primary completion
2011-02-01
Completion
2011-03-01
First posted
2011-10-03
Last updated
2011-10-03

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01444976. Inclusion in this directory is not an endorsement.